A
Alto Neuroscience, Inc.
ANRO · NYSE · Healthcare · 1.1B
Closing price
$24.37
+1.41% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.7×
Enterprise value / EBITDAEV/EBITDA
-8.8×
Free cash flow yieldFCF yield
-7.4%
Return on equityROE
-41.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.9×
Interest coverage
-26.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.